Landos Biopharma Inc (LABP)
22.21
-0.26
(-1.16%)
USD |
NASDAQ |
May 20, 16:00
Landos Biopharma Market Cap: 69.42M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 20, 2024 | 69.42M |
| May 17, 2024 | 70.24M |
| May 16, 2024 | 69.71M |
| May 15, 2024 | 69.71M |
| May 14, 2024 | 70.17M |
| May 13, 2024 | 69.41M |
| May 10, 2024 | 69.80M |
| May 09, 2024 | 69.89M |
| May 08, 2024 | 69.41M |
| May 07, 2024 | 69.30M |
| May 06, 2024 | 69.24M |
| May 03, 2024 | 69.50M |
| May 02, 2024 | 69.40M |
| May 01, 2024 | 69.54M |
| April 30, 2024 | 69.56M |
| April 29, 2024 | 70.12M |
| April 26, 2024 | 69.59M |
| April 25, 2024 | 70.15M |
| April 24, 2024 | 69.18M |
| April 23, 2024 | 69.09M |
| April 22, 2024 | 68.50M |
| April 19, 2024 | 68.06M |
| April 18, 2024 | 67.84M |
| April 17, 2024 | 67.59M |
| April 16, 2024 | 67.13M |
| Date | Value |
|---|---|
| April 15, 2024 | 67.28M |
| April 12, 2024 | 67.13M |
| April 11, 2024 | 67.04M |
| April 10, 2024 | 67.10M |
| April 09, 2024 | 67.01M |
| April 08, 2024 | 67.01M |
| April 05, 2024 | 67.35M |
| April 04, 2024 | 67.01M |
| April 03, 2024 | 66.98M |
| April 02, 2024 | 67.07M |
| April 01, 2024 | 67.32M |
| March 28, 2024 | 66.95M |
| March 27, 2024 | 66.57M |
| March 26, 2024 | 67.20M |
| March 25, 2024 | 66.70M |
| March 22, 2024 | 24.40M |
| March 21, 2024 | 23.91M |
| March 20, 2024 | 21.79M |
| March 19, 2024 | 21.63M |
| March 18, 2024 | 20.69M |
| March 15, 2024 | 20.69M |
| March 14, 2024 | 20.20M |
| March 13, 2024 | 20.20M |
| March 12, 2024 | 20.35M |
| March 11, 2024 | 19.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
8.048M
Minimum
Mar 17 2023
636.79M
Maximum
Mar 01 2021
153.42M
Average
31.78M
Median
Market Cap Benchmarks
| AbbVie Inc | 292.07B |
| Fusion Pharmaceuticals Inc | 1.825B |
| Masimo Corp | 6.690B |
| Kinnate Biopharma Inc (DELISTED) | -- |
| Invivyd Inc | 268.46M |
Market Cap Related Metrics
| Price to Book Value | 2.998 |
| Price | 22.21 |
| Earnings Yield | -17.96% |